FOXC1–GMDS axis-driven glycolytic reprogramming promotes tumor progression in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype that is highly reliant on glycolytic metabolism. Despite this well-characterized metabolic feature, the molecular mechanisms governing glycolytic fitness and the therapeutic potential to exploit these metabolic adaptations remain poorly defined....